B. Greenwood & G. Targett | 27 Aug 2009 | Parasite Immunology
An unexpectedly large reduction in the burden of malaria has recently been achieved in a number of malaria endemic countries following the scaling up of effective treatment and simple vector control programmes.
Roger Bate & Richard Tren | 22 May 2006 | American Enterprise Institute
This paper warns against the proposed May 2006 World Health Assembly treaty to increase state control of research and development into new drugs.
Pedro L. Alonso et al | 16 Oct 2004 | The Lancet
Development of an effective malaria vaccine could greatly contribute to disease control. RTS,S/AS02A is a pre-erythrocytic vaccine candidate based on Plasmodium falciparum circumsporozoite surface antigen. We aimed to assess vaccine efficacy, immunogenicity, and safety in young African children.